• MitraClip Redux: Mortality Key in COAPT

    Safety and efficacy were a win-win for the MitraClip device in the COAPT trial of moderate-to-severe, symptomatic mitral regurgitation patients with heart failure who had exhausted pharmaceutical options.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details